Clinical Trial Details
| Trial ID: | L1686 |
| Source ID: | NCT01704339 |
| Associated Drug: | Qutenza |
| Title: | Qutenza for Critical Ischaemia in End Stage Renal Failure |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | End Stage Renal Failure|Neuropathic Pain |
| Interventions: | DRUG: QUTENZA |
| Outcome Measures: | Primary: Chronic neuropathic pain, Chronic neuropathic pain as assessed by Visual Analogue Pain Score, 12 weeks | Secondary: Neuropathic pain, As assessed by Brief Pain Inventory, 12 weeks|Quality of Life, Assessed using EQ-5D score, 6 weeks, 12 weeks|Neuropathic pain, As assesses by Visual Analogue Pain Score, 1 week, 6 weeks|Quality of Life, As assessed by Patient Global Impression of Change score, 12 weeks|Safety and tolerability, Skin will be assessed for breaks/ blisters and tolerability including the need for rescue analgesia will be recorded, 1 day, 12 weeks |
| Sponsor/Collaborators: | Sponsor: Emma Aitken |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 20 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2012-12 |
| Completion Date: | 2014-03 |
| Results First Posted: | |
| Last Update Posted: | 2012-10-11 |
| Locations: | Department of Renal Surgery, Western Infirmary, Glasgow, G116NY, United Kingdom |
| URL: | https://clinicaltrials.gov/show/NCT01704339 |
